Niquitin Trópusi Gyümölcs (Nicotine Resinate)

Nicotine Resinate, the active ingredient in Niquitin Trópusi Gyümölcs, is a nicotine replacement therapy presented as an oromucosal preparation for use in adults seeking to reduce nicotine dependence. It works by stimulating nicotinic acetylcholine receptors, helping to alleviate withdrawal symptoms and cravings associated with smoking cessation. The product is formulated for sublingual or buccal absorption, allowing rapid onset of action and convenient dosing without the need for combustion. It is intended for over‑the‑counter purchase in the EU market.

GNH USA supplies Niquitin Trópusi Gyümölcs as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Nicotine Resinate is used in nicotine replacement therapy to support smoking cessation.

- Smoking cessation: assists individuals in quitting tobacco use by reducing cravings. - Nicotine dependence: alleviates withdrawal symptoms in people dependent on nicotine. - Tobacco use disorder: provides a controlled nicotine source to facilitate gradual reduction.

Common Side Effects: - Mouth irritation: mild soreness or tingling in the oral cavity. - Nausea: transient feeling of queasiness after administration. - Headache: mild to moderate headache occurring shortly after use. - Dizziness: occasional light‑headed sensation. - Hiccups: brief episodes of involuntary diaphragm contraction. - Dyspepsia: mild indigestion or stomach discomfort.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Severe hypotension: marked drop in blood pressure leading to faintness. - Cardiac arrhythmia: irregular heart rhythm requiring medical attention. - Bronchospasm: sudden narrowing of the airways causing breathing difficulty. - Seizures: rare convulsive episodes, especially in susceptible individuals.

Before using Niquitin Trópusi Gyümölcs, consider the following precautions: - Cardiovascular assessment: evaluate recent myocardial infarction or unstable angina. - Pregnancy and lactation: safety not established; use only if benefits outweigh risks. - Pediatric use: not recommended for children or adolescents. - Concomitant nicotine products: avoid using multiple nicotine sources simultaneously. - Storage: Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Nicotine Resinate may interact with other substances as follows: Major Interactions (Avoid): - Other nicotine replacement products: risk of nicotine overdose. - Monoamine oxidase inhibitors: potential for exaggerated sympathomimetic effects. Moderate Interactions (Monitor Closely): - Caffeine: may increase stimulation and jitteriness. - Beta‑blockers: nicotine may reduce antihypertensive efficacy. - Antidepressants (e.g., SSRIs): possible alteration of nicotine metabolism. - Alcohol: may enhance side‑effect profile, especially nausea and dizziness.